August 15, 2022
McKesson Corp. and its lawyers from Covington & Burling LLP have "cabined off" discovery in a False Claims Act suit to hide the role of its wholesale pharmaceutical division in an alleged scheme to repackage injectable drugs, counsel for a whistleblower told a Brooklyn federal judge Monday.
August 12, 2021
A simmering struggle between the U.S. Department of Justice and the False Claims Act defense bar over increasingly enormous discovery demands intensified dramatically Thursday as a Covington & Burling LLP attorney denounced a DOJ lawyer for making "sanctionable" allegations about ulterior motives.
July 15, 2021
McKesson Corp. has hit the U.S. Food and Drug Administration with "abusive discovery" demands to browbeat the U.S. Department of Justice into torpedoing a whistleblower's False Claims Act case, according to a fiery DOJ filing in New York federal court.
February 04, 2019
McKesson Corp. must face Omni Healthcare Inc.'s allegations that it violated the False Claims Act by skimming drugs from overfilled vials meant for cancer patients and then selling them to providers, a New York federal judge said Monday.
April 04, 2018
A medical company is accusing pharmaceutical distribution company McKesson Corp. of opening deliberately overfilled sterile vials of drugs, skimming the excess medicine and then transferring the drugs into single-dose pre-filled syringes in a False Claims Act complaint filed on behalf of the government in New York federal court Tuesday.